Runfa Bao
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Surgery top 5%
- Cholangiocarcinoma and Gallbladder Cancer Studies
Papers in
- Surgery 33
- Cholangiocarcinoma and Gallbladder Cancer Studies 33
-
- Cancer-related molecular mechanisms research 3
- MicroRNA in disease regulation 3
- Co-authors
- Yingbin Liu (33 shared papers)Yijun Shu (31 shared papers)Maolan Li (32 shared papers)Hao Weng (25 shared papers)Yang Cao (19 shared papers)Xiangsong Wu (23 shared papers)Jiasheng Mu (16 shared papers)Qian Ding (14 shared papers)
- Journals
- Cancer Letters (4 papers)BMC Cancer (3 papers)Frontiers in Oncology (2 papers)Medical Oncology (2 papers)Tumor Biology (2 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Runfa Bao
47 papers receiving 2.2k citations
Runfa Bao's Hit Papers
Peers
Comparison fields: 5 of 83
- Cancer Research 524
- Surgery 756
- Oncology 302
- Drug Discovery 3
- Molecular Biology 436
Countries citing papers authored by Runfa Bao
This map shows the geographic impact of Runfa Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runfa Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runfa Bao more than expected).
Fields of papers citing papers by Runfa Bao
This network shows the impact of papers produced by Runfa Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runfa Bao. The network helps show where Runfa Bao may publish in the future.
Co-authors
The 25 scholars most cited alongside Runfa Bao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway Hit paper breakdown → | 2014 | 359 |
| 2 | 2014 | 210 | |
| 3 | 2017 | 181 | |
| 4 | 2015 | 111 | |
| 5 | 2014 | 99 | |
| 6 | 2016 | 96 | |
| 7 | 2014 | 85 | |
| 8 | 2013 | 83 | |
| 9 | 2017 | 80 | |
| 10 | 2015 | 69 | |
| 11 | 2014 | 59 | |
| 12 | 2014 | 52 | |
| 13 | 2015 | 51 | |
| 14 | 2016 | 49 | |
| 15 | 2014 | 42 | |
| 16 | 2016 | 41 | |
| 17 | 2015 | 39 | |
| 18 | 2015 | 35 | |
| 19 | 2016 | 34 | |
| 20 | 2013 | 31 |
About Runfa Bao
Runfa Bao is a scholar working on Surgery, Cancer Research, Pharmacology, Oncology and Molecular Biology, having authored 48 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (33 papers), Cancer-related molecular mechanisms research (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), MicroRNA in disease regulation (3 papers), Natural product bioactivities and synthesis (3 papers), Flavonoids in Medical Research (2 papers), Magnolia and Illicium research (1 paper) and Nanoparticle-Based Drug Delivery (1 paper). The work is most often cited by research in Cancer Research (524 citations), Surgery (756 citations), Oncology (302 citations), Drug Discovery (3 citations) and Molecular Biology (436 citations). Runfa Bao has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Yingbin Liu, Yijun Shu, Maolan Li, Hao Weng, Yang Cao, Xiangsong Wu, Jiasheng Mu, Qian Ding, Yunping Hu and Zhujun Tan. Their work appears in journals such as Cancer Letters, BMC Cancer, Frontiers in Oncology, Medical Oncology and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.